Finished dosage facility of Granules in Hyderabad gets 11 U.S. FDA observations
The U.S. FDA issued a warning letter in February 2025 after inspecting the facility in August–September 2024
Attributed summary
The U.S. FDA issued a warning letter in February 2025 after inspecting the facility in August–September 2024
Read the original report — The Hindu Business
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.

